This patent discloses a protein that stimulates production of platelets. This protein may be similar to thrombopoietin and should be investigated further.
This patent provides various morphogens, such as OP-1 for the regeneration of various dendal components, including tooth sockets.
Ketamine is used as an anasthetic in veterinary medicine, as well as for some human uses. This patent teaches various chemical modifications of ketamine that stimulate production of stem cells that are committed to generating platelets. The importance of stimulating platelet production is seen by the number of companies working on either thrombopoietin analogues or antibodies to the...
This patent teaches how to generate in vitro neurons that produce dopamine. The neurons are generated from stem cells through culture in FGF and TGF beta family members, as well as in the presence of feeder cell layers.
This patent teaches how to induce mesenchymal stem cells into chondrocytes (to make cartilage) or osteoblasts (to make bone) through the use of the cytokine called Connective Tissue Growth Factor. This patent is useful for regenerative purposes in the area of injuries, however it is interesting in that the mesenchymal stem cell patents are owned by Osiris and should be licensed in order to...
This patent teaches the use of proteins such as osteogenic protein-1 (OP-1) for stimulation of liver regeneration.
This patent provides various morphogens that can be administered in vivo for the induction of liver regeneration. This patent is useful alone, or in combination with exogenous stem cell delivery for treatment of hepatic disorders. This patent is especially interesting in light of recent work using cord blood stem cells for liver regeneration.
Mesenchymal stem cells are a topic of intense investigation and subject to several clinical trials, including by Osiris Therapeutics who are currently in Phase III for treatment of graft versus host disease. This is one of the older patents on mesenchymal stem cells that teaches the differentiation of mesenchymal stem cells into bone forming cells. This is...
This patent teaches a really interesting way of stimulating myelopoiesis by exposing myeloid precursor cells to a compound called IgE binding factor. Myeloid precursors are important for generation of neutrophils and therefore protecting from opportunistic diseases. Stimulation of myeloid cells by this approach may be useful for immune modulation as well, some papers suggest that myeloid...
This patent teaches how to induce differentiation of neurons, as well as to enhance their survival using a variety of growth factors, including leukemia inhibitory factor.